Valuation: SMAIO

Market Cap 4.62Cr 5.26Cr 4.3Cr 3.94Cr 7.41Cr 506.42Cr 7.52Cr 51Cr 20Cr 248.97Cr 20Cr 19Cr 860.82Cr P/E 2026 *
-21x
P/E 2027 * 205x
Enterprise Value 4.47Cr 5.09Cr 4.16Cr 3.81Cr 7.17Cr 489.97Cr 7.28Cr 49Cr 19Cr 240.89Cr 19Cr 19Cr 832.87Cr EV / Sales 2026 *
4.06x
EV / Sales 2027 * 2.83x
Free-Float
29.17%
Yield 2026 *
-
Yield 2027 * -
1 day+1.22%
1 week-0.72%
Current month+6.96%
1 month+9.79%
3 months+8.64%
6 months+18.57%
Current year+32.80%
1 week 7.66
Extreme 7.66
8.44
1 month 7.46
Extreme 7.46
8.94
Current year 6
Extreme 6
9.1
1 year 5.5
Extreme 5.5
9.1
3 years 2.14
Extreme 2.14
9.1
5 years 1.9
Extreme 1.9
9.1
10 years 1.9
Extreme 1.9
9.1
Manager TitleAgeSince
Chief Executive Officer - 29/12/2008
Director of Finance/CFO - 01/06/2022
Chief Tech/Sci/R&D Officer - 01/07/2020
Director TitleAgeSince
Chairman - 30/07/2021
Change 5-day change 1-year change 3-year change Capi.($)
+1.22%-0.72%-2.35%+237.40% 5.25Cr
+0.86%+1.22%+48.18%+159.84% 1,05700Cr
+1.62%+4.09%+55.34%+53.96% 62TCr
+0.87%+1.93%+35.93%+81.16% 45TCr
+1.60%+6.25%+33.95%+29.84% 34TCr
-0.60%+1.52%+35.68%+39.76% 30TCr
-0.14%+0.60%+16.17%+17.53% 26TCr
+0.09%-2.82%-28.29%-41.71% 22TCr
+1.15%+2.98%+22.25%+60.22% 20TCr
-1.23%-3.18%+14.85%+67.41% 16TCr
Average +0.59%+0.51%+23.17%+70.54% 36.14TCr
Weighted average by Cap. +0.76%+1.57%+35.69%+77.53%

Financials

2026 *2027 *
Net sales 1.1Cr 1.25Cr 1.02Cr 93.87L 1.76Cr 120.61Cr 1.79Cr 12Cr 4.75Cr 59Cr 4.7Cr 4.6Cr 205.02Cr 1.6Cr 1.82Cr 1.49Cr 1.37Cr 2.57Cr 175.43Cr 2.61Cr 18Cr 6.9Cr 86Cr 6.84Cr 6.69Cr 298.21Cr
Net income -22.5L -25.62L -20.92L -19.2L -36.08L -25Cr -36.63L -2.48Cr -97.08L -12Cr -96.17L -94.1L -42Cr 2L 3L 2L 2L 4L 2.74Cr 4L 27.61L 10.79L 1.35Cr 10.69L 10.46L 4.66Cr
Net Debt -15L -17.08L -13.95L -12.8L -24.05L -16Cr -24.42L -1.66Cr -64.72L -8.09Cr -64.11L -62.73L -28Cr -9L -10.25L -8L -8L -14.43L -9.87Cr -14.65L -99.39L -38.83L -4.85Cr -38.47L -37.64L -17Cr
Logo SMAIO
S.M.A.I.O « Software, Machines and Adaptive Implants in Orthopaedics » is specialized in the design, manufacture and marketing of implantable medical devices for the treatment of spinal pathologies. The company offers the Kheiron Spinal Fixation System, a device that incorporates many implants, intended for the immobilization and stabilization of spinal segments as an adjunct to fusion of the thoracic, lumbar and/or sacral spine. In addition, S.M.A.I.O has developed the Keops and Balance Analyzer 3D surgical planning and patient database management software, and the company also offers training programs. Net sales break down by source of revenue between sales of products (98.9%) and services (1.1%). Net sales are distributed geographically as follows: France (9.8%), Europe (12.2%), the United States (76.2%), Oceania (1%), Middle East and Africa (0.7%) and Canada (0.1%).
Employees
45
Date Price Change Volume
24/26/24 8.300 +1.22% 312
23/26/23 €8.200 +5.13% 396
22/26/22 €7.800 -7.14% 404
21/26/21 €8.400 +0.72% 169
20/26/20 €8.340 +10.32% 3,069
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
8.200EUR
Average target price
8.200EUR
Spread / Average Target
0.00%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ALSMA Stock